Patents by Inventor Rolf Treckmann

Rolf Treckmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8232369
    Abstract: The present invention relates to a method for precipitation of peptide where the mixing step of the peptide with the precipitation aid and the precipitation itself are specially separated.
    Type: Grant
    Filed: November 27, 2007
    Date of Patent: July 31, 2012
    Assignees: Talecris Biotherapeutics, Inc., Bayer Technology Services GmbH
    Inventors: Hans-Jürgen Henzler, Stephan Kirchner, Dirk Havekost, Klaus Kaiser, Jörg Kauling, Richard Pasquinelli, Rolf Treckmann
  • Publication number: 20100093982
    Abstract: The present invention relates to a method for precipitation of peptide where the mixing step of the peptide with the precipitation aid and the precipitation itself are specially separated.
    Type: Application
    Filed: November 27, 2007
    Publication date: April 15, 2010
    Applicant: TALECRIS BIOTHERAPEUTICS, INC.
    Inventors: Hans-Jurgen Henzler, Stephan Kirchner, Dirk Havekost, Klaus Kaiser, Jörg Kauling, Richard Pasquinelli, Rolf Treckmann
  • Patent number: 7695675
    Abstract: A method of inactivating microorganisms such as viruses within a fluid such as a biological fluid is disclosed. The method includes the steps of providing a UV reactor, which may take the form of an elongated generally annular reaction chamber surrounding at least one elongated UV lamp, moving the fluid within the reaction chamber in a primary flow directed along the length of the UV lamp, and inducing a circulating secondary flow within the fluid with the secondary flow being superimposed on the primary flow. As the fluid moves through the reaction chamber in the primary flow, it is circulated repeatedly toward and away from the UV lamp in the circulating secondary flow to provide uniform and controllable exposure of the entire volume of fluid to ultraviolet radiation. Microorganisms such as viruses are thus inactivated while desirable components in the fluid, such as proteins, are preserved without the use of a free radical scavenger.
    Type: Grant
    Filed: March 14, 2005
    Date of Patent: April 13, 2010
    Assignees: Bayer Healthcare LLC, Bayer Aktiengesellschaft
    Inventors: Klaus Kaiser, Hans-Juergen Henzler, Joerg Kauling, Rolf Treckmann, Kathryn Remington, Cynthia J. Galloway
  • Publication number: 20070003430
    Abstract: A method of inactivating microorganisms such as viruses within a fluid such as a biological fluid is disclosed. The method includes the steps of providing a UV reactor, which may take the form of an elongated generally annular reaction chamber surrounding at least one elongated UV lamp, moving the fluid within the reaction chamber in a primary flow directed along the length of the UV lamp, and inducing a circulating secondary flow within the fluid with the secondary flow being superimposed on the primary flow. As the fluid moves through the reaction chamber in the primary flow, it is circulated repeatedly toward and away from the UV lamp in the circulating secondary flow to provide uniform and controllable exposure of the entire volume of fluid to ultraviolet radiation. Microorganisms such as viruses are thus inactivated while desirable components in the fluid, such as proteins, are preserved without the use of a free radical scavenger.
    Type: Application
    Filed: March 14, 2005
    Publication date: January 4, 2007
    Inventors: Klaus Kaiser, Hans-Juergen Henzler, Joerg Kauling, Rolf Treckmann, Kathryn Remington, Cynthia Galloway
  • Publication number: 20030049809
    Abstract: A method of inactivating microorganisms such as viruses within a fluid such as a biological fluid is disclosed. The method includes the steps of providing a UV reactor, which may take the form of an elongated generally annular reaction chamber surrounding at least one elongated UV lamp, moving the fluid within the reaction chamber in a primary flow directed along the length of the UV lamp, and inducing a circulating secondary flow within the fluid with the secondary flow being superimposed on the primary flow. As the fluid moves through the reaction chamber in the primary flow, it is circulated repeatedly toward and away from the UV lamp in the circulating secondary flow to provide uniform and controllable exposure of the entire volume of fluid to ultraviolet radiation. Microorganisms such as viruses are thus inactivated while desirable components in the fluid, such as proteins, are preserved without the use of a free radical scavenger.
    Type: Application
    Filed: July 16, 2002
    Publication date: March 13, 2003
    Inventors: Klaus Kaiser, Hans-Juergen Henzler, Joerg Kauling, Rolf Treckmann, Kathryn Remington, Cynthia J. Galloway
  • Patent number: 5250658
    Abstract: According to the invention, a special process for isolating polycarbonate from methylene chloride at temperatures of 30.degree. to 80.degree. C. in the form of a powder with residual solvent contents below 5% by weight is started up as a continuous process by starting up in a two-component nozzle, in which CO.sub.2 -containing fluid and the polymer solution are continuously combined, with a large excess of CO.sub.2 and then allowing the polycarbonate/methylene chloride/CO.sub.2 fluid system to pass through the gel-forming range of the polycarbonate/methylene chloride/CO.sub.2 phase diagram with continuous reduction of the CO.sub.2 throughput to a ratio of CO.sub.2 to organic solution of 4:1 to 2:1. The process started up in this way has a particularly long useful life.
    Type: Grant
    Filed: September 4, 1992
    Date of Patent: October 5, 1993
    Assignee: Bayer Aktiengesellschaft
    Inventors: Hanns-Ingolf Paul, Rolf Treckmann, Gunther Weymans, Jurgen Kirsch, Wolfgang Herrig
  • Patent number: 5229486
    Abstract: A process for isolating polymers from their solvents by addition of fluids containing carbon dioxide at temperatures of 30.degree. to 280.degree. C. and under pressures of 1 to 1,000 bar is disclosed. The process is characterized in that the concentration of the polymers in their solvents is between 5% and 80% by weight and the fluid containing carbon dioxide consists of at least 50% by weight carbon dioxide.
    Type: Grant
    Filed: December 11, 1991
    Date of Patent: July 20, 1993
    Assignee: Bayer Aktiengesellschaft
    Inventors: Hanns-Ingolf Paul, Rolf Treckmann, Gunther Weymans, Jurgen Kirsch, Jurgen Heuser, Klaus Elgeti
  • Patent number: 5221731
    Abstract: A continuous process for the isolation of polycarbonates from a solution of polycarbonate in methylene chloride at temperatures of 30.degree. to 80.degree. C. is disclosed. The process which yields polycarbonate in powder form having residual solvent content of less than 5% by weight, is characterized in that it entails the following steps:a) obtaining a solution of polycarbonate in methylene chloride containing 10 to 40 percent polycarbonate, said percent being relative to the total weight of the polycarbonate solution,b) mixing into said solution under pressures of 10 to 50 bar and at temperatures of 30.degree. to 50.degree. C. a fluid containing carbon dioxide resulting in a non-gelling polycarbonate/methylene/chloride/dioxide pressurized system, in which between 10 and 12% CO.sub.2 are dissolved,c) mixing said pressurized system in a two-component nozzle with additional fluid containing carbon dioxide under a pressure of 50 to 300 bar and at temperatures of 40.degree. to 150.degree. C.
    Type: Grant
    Filed: May 26, 1992
    Date of Patent: June 22, 1993
    Assignee: Bayer Aktiengesellschaft
    Inventors: Gunther Weymans, Jurgen Kirsch, Wolfgang Herrig, Hanns-Ingolf Paul, Rolf Treckmann